bioRxivCancer Biology
A mechanistic model of malignant transformation in vestibular schwannoma
C. G. Paterson, I. Bozic, M. J. Smith, X. Hoad, D. G. R. Evans
Abstract
A vestibular schwannoma (VS) is a relatively rare, benign tumour of the eighth cranial nerve, often involving alterations to the gene NF2. Previous mathematical models of schwannoma incidence have not attempted to account for alterations in specific genes, and could not distinguish between point mutations and loss of heterozygosity (LOH). Here, we present a mechanistic approach to modelling initiation and malignant transformation in Schwannoma. Each parameter is associated with a specific gene or mechanism operative in Schwann cells, and can be determined by combining incidence data with empirical frequencies of pathogenic variants and LOH. This results in new estimates for the base pair mutation rate u = 4.48 x 10-10 and the rate of LOH = 2.03 x 10-6/yr in Schwann cells. In addition to new parameter estimates, we extend the approach to estimate the risk of both spontaneous and radiation-induced malignant transformation. We conclude that radiotherapy is likely to have a negligible excess risk of malignancy for sporadic VS, with a possible exception of rapidly growing tumours.
- organism: human
- research focus: cancer & tumor microenvironment
- approach: mechanistic / dynamical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High-Dimensional Imaging of Vestibular Schwannoma Reveals Distinctive Immunological Networks Across Histomorphic Niches in NF2-related Schwannomatosis
A. P. Jones, M. J. Haley, … K. Couper·bioRxiv·Apr 9, 2024
- Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state
T. F. Barrett, B. Patel, … A. H. Kim·bioRxiv·Nov 18, 2022
- Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.
Maxwell Thomas Laws, Dhruval Bhatt, … Prashant Chittiboina·bioRxiv·Nov 15, 2025
- Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
C. C. MacKenzie, J. Vitte, … A. I. McClatchey·bioRxiv·Dec 31, 2020
- Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-SWN
Jérémie Vitte, Christine Chiasson-MacKenzie, … Marco Giovannini·bioRxiv·Sep 16, 2026
- Direct and abscopal anti-tumor responses elicited by peripheral nerve schwannoma irradiation synergize with anti-PD1 treatment in vestibular schwannoma models
Zhenzhen Yin, Simeng Lu, … Lei Xu·bioRxiv·Dec 29, 2024